SCHEMBL3772088

SCHEMBL3772088

Fc1cc(Cl)ccc1C(=Cc1cccc(Cl)c1)CCl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FBP1 P09467 1/20 0.40
CHRM5 P08912 1/20 0.38
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
PTGS1 P23219 2/20 0.37
CHAT P28329 1/20 0.36
ALDH1A1 P00352 4/20 0.35
KDM4E B2RXH2 2/20 0.35
KMT2A Q03164 2/20 0.35
POLB P06746 1/20 0.35
PKM P14618 1/20 0.35
MAOB P27338 1/20 0.35
KIF20A O95235 1/20 0.35
MAPK1 P28482 1/20 0.35
HIF1A Q16665 1/20 0.35
GRIN2D O15399 2/20 0.35
GRIN3B O60391 2/20 0.35
GRIN1 Q05586 2/20 0.35
GRIN2A Q12879 2/20 0.35
GRIN2B Q13224 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3663676 1.00 FBP1 (0.40) FBP1CHRM5CYP1A2CYP2C9PTGS1
SCHEMBL3768883 0.92 PTGS1 (0.41) FBP1CHRM5CYP1A2CYP2C9PTGS1
SCHEMBL3768878 0.92 PTGS1 (0.41) FBP1CHRM5CYP1A2CYP2C9PTGS1
SCHEMBL3777736 0.86 PTGS1 (0.39) FBP1PTGS1ALDH1A1KDM4EPOLB
SCHEMBL3665474 0.86 PTGS1 (0.39) FBP1PTGS1ALDH1A1KDM4EPOLB
SCHEMBL3769833 0.84 MDM2 (0.40) FBP1CHRM5CYP1A2CYP2C9PTGS1
SCHEMBL3769829 0.84 MDM2 (0.40) FBP1CHRM5CYP1A2CYP2C9PTGS1
SCHEMBL3663635 0.81 NFE2L2 (0.38) CYP1A2CYP2C9PTGS1ALDH1A1KDM4E
SCHEMBL3768738 0.81 NFE2L2 (0.38) CYP1A2CYP2C9PTGS1ALDH1A1KDM4E
SCHEMBL3661934 0.79 NFE2L2 (0.41) ALDH1A1KMT2AMAPK1HIF1ACYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100317515-A1 Azolylmethyloxiranes, use Thereof and Agents Containing the Same BASF SE (DE) 2010-12-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100317515-A1 Azolylmethyloxiranes, use Thereof and Agents Containing the Same XDH, NOX5, TET1 FBP1 855/4885CHRM5 1679/4885CYP1A2 28/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.